ISDA

Entry Detail

PDB ID:

4X7K

Keywords:

Title:

Co-crystal Structure of PERK bound to 4-{2-amino-3-[5-fluoro-2-(methylamino)quinazolin-6-yl]-4-methylbenzoyl}-1-methyl-2,5-diphenyl-1,2-dihydro-3H-pyrazol-3-one inhibitor

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2014-12-09

Release Date:

2015-01-28

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.19

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3
Mutations:D937N, Deletion of 670-874
Chain IDs:A
Chain Length:317
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9NZJ5 Pfam ID:PF00069 EC:2.7.11.1

Ligand Molecules

3Z3

GOL

TLA

Primary Citation

Discovery of 1H-Pyrazol-3(2H)-ones as Potent and Selective Inhibitors of Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK).

Smith, A.L, Andrews, K.L, Beckmann, H, Bellon, S.F, Beltran, P.J, Booker, S, Chen, H, Chung, Y.A, D'Angelo, N.D, Dao, J, Dellamaggiore, K.R, Jaeckel, P, Kendall, R, Labitzke, K, Long, A.M, Materna-Reichelt, S, Mitchell, P, Norman, M.H, Powers, D, Rose, M, Shaffer, P.L, Wu, M.M, Lipford, J.R.Show

J.Med.Chem. 58 1426 1441 (2015)

PMID: 25587754 DOI: 10.1021/jm5017494

Abstact

The structure-based design and optimization of a novel series of selective PERK inhibitors are described resulting in the identification of 44 as a potent, highly selective, and orally active tool compound suitable for PERK pathway biology exploration both in vitro and in vivo.

Legend

Protein

Chemical

Disease

Primary Citation of related structures